Your browser doesn't support javascript.
loading
Ophthalmic drug effects on the amyloidogenesis of a transforming growth factor ß-induced protein (TGFBIp) peptide fragment.
Chang, Chia-Yu; Wang, Steven S-S; Lai, You-Ren; Koh, Won-Gun; Wu, Josephine W; Chiang, Yi-Hui.
Afiliación
  • Chang CY; Department of Chemical Engineering, National Taiwan University, Taipei, 10617, Taiwan.
  • Wang SS; Department of Chemical Engineering, National Taiwan University, Taipei, 10617, Taiwan.
  • Lai YR; Department of Chemical Engineering, National Taiwan University, Taipei, 10617, Taiwan.
  • Koh WG; Department of Chemical and Biomolecular Engineering, Yonsei University, South Korea.
  • Wu JW; Department of Optometry, Yuanpei University of Medical Technology, Hsinchu City, 30015, Taiwan; Department of Optometry, Mackay Medical College, New Taipei City, 252, Taiwan. Electronic address: P02431@mmc.edu.tw.
  • Chiang YH; Department of Ophthalmology, En Chu Kong Hospital, New Taipei City, 237, Taiwan. Electronic address: gracechiang168@gmail.com.
Exp Eye Res ; 244: 109932, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38762008
ABSTRACT
Drugs that can treat one disease may either be detrimental or beneficial toward another due to possible cross-interactions. Therefore, care in choosing a suitable drug for patients with multiple diseases is crucial in successful patient management. This study explores several currently available ophthalmic drugs used to treat common ocular diseases to understand how they can affect the amyloidogenesis of a transforming growth factor ß-induced protein (TGFBIp) peptide fragment found in abundance in the corneal protein aggregation deposits of lattice corneal dystrophy (LCD) patients. Results from this study provided supporting evidence that some drugs intended to treat other diseases can enhance or inhibit fibrillar aggregation of TGFBIp peptide, which may have potential implication of affecting the disease progression of LCD by either worsening or ameliorating it. Comparisons of the different properties of ophthalmic compounds explored in this study may also provide some guidance for future design of drugs geared toward the treatment of LCD.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Distrofias Hereditarias de la Córnea / Proteínas de la Matriz Extracelular / Factor de Crecimiento Transformador beta Límite: Humans Idioma: En Revista: Exp Eye Res Año: 2024 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Distrofias Hereditarias de la Córnea / Proteínas de la Matriz Extracelular / Factor de Crecimiento Transformador beta Límite: Humans Idioma: En Revista: Exp Eye Res Año: 2024 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Reino Unido